DC
AVEO

Diametric Capital’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Diametric Capital’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-29,909
Closed -$447K – 465
2022
Q4 		$447K Buy
+29,909
New +$414K 0.22% 150

Diametric Capital's AVEO Position: Q1 2023 in Review

Diametric Capital sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 29,909 shares — an estimated $447K sold.

Diametric Capital first reported a position in AVEO in Q4 2022 and held it in 1 quarter. The position peaked at $447K in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

  • Diametric Capital reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Diametric Capital sold 29,909 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $447K.
  • Diametric Capital first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
  • Diametric Capital's AVEO Pharmaceuticals, Inc. position peaked at $447K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Diametric Capital's 13F filing for Q1 2023, filed 11 May 2023.